Retinal Drusen Are More Common and Larger in Systemic Lupus Erythematosus With Renal Impairment
- PMID: 35497809
- PMCID: PMC9039474
- DOI: 10.1016/j.ekir.2022.01.1063
Retinal Drusen Are More Common and Larger in Systemic Lupus Erythematosus With Renal Impairment
Abstract
Introduction: Complement has been implicated in systemic lupus erythematosus (SLE) pathogenesis on the basis of the associations with inherited complement defects and genome-wide association study risk alleles, glomerular deposits, reduced serum levels, and occasional reports of retinal drusen. This study examined drusen in SLE and their clinical significance.
Methods: This cross-sectional observational study compared individuals with SLE recruited from renal and rheumatology clinics with hospital controls. Participants were reviewed for clinical features and underwent imaging with a nonmydriatic retinal camera. Deidentified images were examined by 2 trained graders for drusen number and size using a grid overlay.
Results: The cohort with SLE (n = 65) comprised 55 women (85%) and 10 men (15%) with a median age of 47 years (interquartile range 35-59), where 23 (35%) were of southern European or Asian ancestry, and 32 (49%) had biopsy-proven lupus nephritis. Individuals with SLE had higher mean drusen numbers than controls (27 ± 60, 3 ± 9, respectively, P = 0.001), more drusen counts ≥10 (31, 48% and 3, 5%, respectively, P < 0.001), and more medium-large drusen (14, 22% and 3, 5%, respectively, P < 0.001). In SLE, mean drusen counts were higher, and drusen were larger, with an estimated glomerular filtration rate (eGFR) <90 ml/min per 1.73 m2 (P = 0.02, P = 0.02, respectively) or class IV nephritis (P = 0.03, P = 0.02).
Conclusion: Drusen composition resembles that of glomerular immune deposits. CFH controls complement activation in the extracellular matrix and CFH risk variants are shared by drusen in macular degeneration and by SLE. CFH represents a possible treatment target for SLE especially with renal impairment.
Keywords: SLE; complement; drusen; immune complexes; impaired kidney function; lupus nephritis.
© 2022 International Society of Nephrology. Published by Elsevier Inc.
Figures



Similar articles
-
Increased retinal drusen in IgA glomerulonephritis are further evidence for complement activation in disease pathogenesis.Sci Rep. 2022 Oct 31;12(1):18301. doi: 10.1038/s41598-022-21386-y. Sci Rep. 2022. PMID: 36316518 Free PMC article.
-
Retinal drusen in glomerulonephritis with or without immune deposits suggest systemic complement activation in disease pathogenesis.Sci Rep. 2022 May 17;12(1):8234. doi: 10.1038/s41598-022-12111-w. Sci Rep. 2022. PMID: 35581312 Free PMC article.
-
Drusen-like Deposits in Young Adults Diagnosed With Systemic Lupus Erythematosus.Am J Ophthalmol. 2017 Mar;175:68-76. doi: 10.1016/j.ajo.2016.11.014. Epub 2016 Dec 7. Am J Ophthalmol. 2017. PMID: 27939560
-
Retinal disease in the C3 glomerulopathies and the risk of impaired vision.Ophthalmic Genet. 2016 Dec;37(4):369-376. doi: 10.3109/13816810.2015.1101777. Epub 2016 Feb 25. Ophthalmic Genet. 2016. PMID: 26915021 Review.
-
Complement in Lupus Nephritis: New Perspectives.Kidney Dis (Basel). 2015 Sep;1(2):91-9. doi: 10.1159/000431278. Epub 2015 Jun 30. Kidney Dis (Basel). 2015. PMID: 27536669 Free PMC article. Review.
Cited by
-
Increased retinal drusen in IgA glomerulonephritis are further evidence for complement activation in disease pathogenesis.Sci Rep. 2022 Oct 31;12(1):18301. doi: 10.1038/s41598-022-21386-y. Sci Rep. 2022. PMID: 36316518 Free PMC article.
-
Associations Between Autoimmune Disease and the Development of Age-Related Macular Degeneration.Invest Ophthalmol Vis Sci. 2023 Dec 1;64(15):45. doi: 10.1167/iovs.64.15.45. Invest Ophthalmol Vis Sci. 2023. PMID: 38153747 Free PMC article.
References
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous